[#item_full_content] The DOJ order immediately shifts FDA-approved and state-licensed cannabis products to Schedule III, lowering barriers to research and easing tax burdens on cannabis companies
Read More
[#item_full_content] The DOJ order immediately shifts FDA-approved and state-licensed cannabis products to Schedule III, lowering barriers to research and easing tax burdens on cannabis companies
Read More